🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT03695887
Recruiting Phase EARLY_PHASE1

A Pilot Trial of Disposable Nitrous Oxide Canisters in Providing Pain Control During Burn Dressing Changes

NCT03695887 · tracked via the Priya Life Science Canada tracker
Phase
Phase EARLY_PHASE1
Started
2019-10-01
Last updated
2026-05-14

Condition(s) studied

BurnsPain, Acute

Investigational drug(s) / intervention(s)

Nitrous Oxide Inhalant ProductPlacebo

Nitrous Oxide Inhalant Product: Nitrous Oxide Inhalant Product

Placebo: Inactive comparator

Study summary

Improvements in burn care have resulted in increased survival. Despite these improved outcomes one of the leading challenges of burn care remains providing adequate analgesia during routine wound care and dressing changes. The traditional use of narcotics is challenging as the therapeutic window between analgesia and suppression of breathing becomes narrow with the intense pain and high doses of narcotics needed for dressing changes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion criteria * adult burn patients admitted to the Health Sciences Centre * total body surface area burned of 5-20% Exclusion criteria * admitted to intensive care unit * unable to participate in the measurement outcomes (sedated, cognitively impaired, unable to understand English or visually impaired) * medical condition that precludes using nitrous oxide (respiratory disease and significant cardiovascular disease 5). * pregnant * physically unable to hold the canister * \<90% SaO2 on room air * face burn * pre-injury narcotics (relative exclusion) * use of IV ketamine * pre-existing lung injury

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Manitoba Winnipeg Manitoba Recruiting

More University of Manitoba trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03695887 on ClinicalTrials.gov ↗ ← All trials in Canada